Patent · US Active

Transdermal delivery rate control using amorphous pharmaceutical compositions

US8784878B2 · kind B2 · utility

0Cited by
48References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 11, 2012
Grant dateJul 22, 2014
Priority date
Expiry dateDec 30, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P33/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A pharmaceutical composition for transdermal delivery comprising

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.